These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22354735)

  • 1. Systemic complement profiling in multiple sclerosis as a biomarker of disease state.
    Ingram G; Hakobyan S; Hirst CL; Harris CL; Loveless S; Mitchell JP; Pickersgill TP; Robertson NP; Morgan BP
    Mult Scler; 2012 Oct; 18(10):1401-11. PubMed ID: 22354735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma C4a levels in multiple sclerosis correlate with disease activity.
    Ingram G; Hakobyan S; Robertson NP; Morgan BP
    J Neuroimmunol; 2010 Jun; 223(1-2):124-7. PubMed ID: 20409594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis.
    Tatomir A; Talpos-Caia A; Anselmo F; Kruszewski AM; Boodhoo D; Rus V; Rus H
    Immunol Res; 2017 Dec; 65(6):1103-1109. PubMed ID: 29116612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
    Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
    Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid complement system biomarkers in demyelinating disease.
    Zelek WM; Fathalla D; Morgan A; Touchard S; Loveless S; Tallantyre E; Robertson NP; Morgan BP
    Mult Scler; 2020 Dec; 26(14):1929-1937. PubMed ID: 31701790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.
    Veszeli N; Füst G; Csuka D; Trauninger A; Bors L; Rozsa C; Nagy Z; Jobbágy Z; Eizler K; Prohászka Z; Varga L; Illes Z
    Mol Immunol; 2014 Feb; 57(2):200-9. PubMed ID: 24172223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis.
    Vedeler CA; Matre R; Sadallah S; Schifferli J
    J Neuroimmunol; 1996 Jun; 67(1):17-20. PubMed ID: 8707926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.
    Sanders ME; Koski CL; Robbins D; Shin ML; Frank MM; Joiner KA
    J Immunol; 1986 Jun; 136(12):4456-9. PubMed ID: 3711661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis.
    Koudriavtseva T; Stefanile A; Fiorelli M; Lapucci C; Lorenzano S; Zannino S; Conti L; D'Agosto G; Pimpinelli F; Di Domenico EG; Mandoj C; Giannarelli D; Donzelli S; Blandino G; Salvetti M; Inglese M
    Front Immunol; 2020; 11():548604. PubMed ID: 33193314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between serum thyroxine and complements in patients with multiple sclerosis and neuromyelitis optica.
    Zhang B; Jiang Y; Yang Y; Peng F; Hu X
    Neuro Endocrinol Lett; 2008 Apr; 29(2):256-60. PubMed ID: 18404143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.
    Aeinehband S; Lindblom RP; Al Nimer F; Vijayaraghavan S; Sandholm K; Khademi M; Olsson T; Nilsson B; Ekdahl KN; Darreh-Shori T; Piehl F
    PLoS One; 2015; 10(4):e0122048. PubMed ID: 25835709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of complement proteins in cerebrospinal fluid from active multiple sclerosis patients.
    Li Y; Qin Z; Yang M; Qin Y; Lin C; Liu S
    J Cell Biochem; 2011 Jul; 112(7):1930-7. PubMed ID: 21445879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terminal component of complement C9 in CSF and plasma of patients with MS and aseptic meningitis.
    Halawa I; Lolli F; Link H
    Acta Neurol Scand; 1989 Aug; 80(2):130-5. PubMed ID: 2816275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mannose binding lectin mediated complement pathway in multiple sclerosis.
    Kwok JY; Vaida F; Augst RM; Yu DY; Singh KK
    J Neuroimmunol; 2011 Oct; 239(1-2):98-100. PubMed ID: 21911261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.
    Wu A; Zhong X; Wang H; Xu W; Cheng C; Dai Y; Bao J; Qiu W; Lu Z; Hu X
    Can J Neurol Sci; 2012 Nov; 39(6):813-20. PubMed ID: 23041403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic and complement markers in extracellular vesicles in multiple sclerosis.
    Bhargava P; Nogueras-Ortiz C; Kim S; Delgado-Peraza F; Calabresi PA; Kapogiannis D
    Mult Scler; 2021 Apr; 27(4):509-518. PubMed ID: 32669030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal activation of the complement system and disability in multiple sclerosis.
    Sellebjerg F; Jaliashvili I; Christiansen M; Garred P
    J Neurol Sci; 1998 May; 157(2):168-74. PubMed ID: 9619641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.